TG Therapeutics, Inc. (TGTX)
Pre-market:
| Previous close | 13.47 |
| Open | 13.66 |
| Bid | 13.31 x 600 |
| Ask | 13.34 x 600 |
| Day's range | 13.22 - 13.85 |
| 52-week range | 6.46 - 35.67 |
| Volume | |
| Avg. volume | 3,469,012 |
| Market cap | 2.057B |
| Beta (5Y monthly) | 2.32 |
| PE ratio (TTM) | 148.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Recent Price Movement Underpinned By Its Weak Fundamentals?
It is hard to get excited after looking at TG Therapeutics' (NASDAQ:TGTX) recent performance, when its stock has...
- Insider Monkey
13 Best Biotech Stocks To Buy Under $20
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
- Insider Monkey
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2023 Earnings Call Transcript
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2023 Earnings Call Transcript February 28, 2024 TG Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.12. TG Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to […]
